SCHEMBL4103205

SCHEMBL4103205

N=C(N)n1cncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2380957 0.98
SCHEMBL14385217 0.75
SCHEMBL1774032 0.75
SCHEMBL14385225 0.75
SCHEMBL24211656 0.69 ALDH1A1 (0.35)
SCHEMBL1072036 0.69 ALDH1A1 (0.35)
SCHEMBL7268279 0.69 ALDH1A1 (0.43)
SCHEMBL10862914 0.69 ALDH1A1 (0.35)
SCHEMBL7651462 0.67 ALDH1A1 (0.34)
SCHEMBL4100563 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120072107-A Method for predicting eutectic salt of tetrazole 三峡大学 2025-05-30 CN claimed
CN-118290443-A Chromone heterocyclic compound, and preparation method and application thereof 中国科学院上海药物研究所 2024-07-05 CN claimed
EP-3331959-B1 ANIONIC CURABLE COMPOSITIONS DESIGNER MOLECULES INC (US) 2022-10-05 EP claimed
US-20220098432-A1 MOISTURE-CURABLE POLYOLEFIN FORMULATION DOW GLOBAL TECHNOLOGIES LLC (US) 2022-03-31 US claimed
CN-113025322-A High-fluorescence carbon dot powder, preparation method thereof and application thereof in nitroimidazole drug detection 武汉轻工大学 2021-06-25 CN claimed
EP-3010930-B1 PEPTIDE-RESIN CONJUGATE AND USE THEREOF CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S A (GR) 2019-09-18 EP claimed
CN-105085328-B A kind of synthetic method of Peramivir trihydrate 广州南新制药有限公司 2018-06-29 CN claimed
EP-2542889-B1 LIGAND GUANIDINYL FUNCTIONALIZED POLYMERS 3M INNOVATIVE PROPERTIES CO (US) 2015-03-25 EP claimed
CN-103524383-A Method for preparing peramivir SHANDONG LUOXIN PHARMACY STOCK 2014-01-22 CN claimed
EP-0684227-B1 Process for the manufacture of guanidines HOFFMANN LA ROCHE (CH) 1998-06-24 EP claimed
EP-0684227-A2 Process for the manufacture of guanidines F. Hoffmann-La Roche AG (CH) 1995-11-29 EP claimed
CN-120072107-A Method for predicting eutectic salt of tetrazole 三峡大学 2025-05-30 CN disclosed
EP-3604305-B1 NOVEL PYRIDONE CARBOXYLIC ACID DERIVATIVE OR SALT THEREOF WAKUNAGA PHARMA CO LTD (JP) 2024-08-28 EP disclosed
CN-118290443-A Chromone heterocyclic compound, and preparation method and application thereof 中国科学院上海药物研究所 2024-07-05 CN disclosed
US-20240024488-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2024-01-25 US disclosed
CN-1118346-A Process for the manufacture of guanidines HOFFMANN LA ROCHE (CH) 1996-03-13 CN disclosed
EP-0684227-A2 Process for the manufacture of guanidines F. Hoffmann-La Roche AG (CH) 1995-11-29 EP disclosed
EP-0684227-A2 Process for the manufacture of guanidines F. Hoffmann-La Roche AG (CH) 1995-11-29 EP disclosed
US-5453514-A Diabetes YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1995-09-26 US disclosed
WO-1995022515-A1 COMBINATION OF ACTIVE SUBSTANCES FOR INHIBITING OR REGULATING NITRIFICATION SKW STICKSTOFFWERKE PIESTERITZ GMBH (DE) 1995-08-24 WO disclosed